Spinoff and activist will benefit Glaxo

Pharmaceutical giant GlaxoSmithKline has stayed in an narrow range of $33 to $48 in the past five years as it struggled with high costs and poor acquisitions.
The company now plans to re energize its growth by spinning off its consumer business as a separate company… Read More

You’ll benefit as Philips pares back

Dutch electronics giant Philips started up in 1891 as a maker of light bulbs and radios. Over the following decades, it has added a wide variety of other consumer products, including television sets, kitchen appliances and personal grooming products.
Philips is now preparing to sell or… Read More

This sale is just as good as a spinoff

European industrial conglomerate ABB has opted to sell its struggling power grid business instead of spinning it off. That will nonetheless unlock value and let the company continue to reward investors.
ABB LTD. ADRs $26 is a buy. The company (New York symbol ABB; Manufacturing & Industry sector;… Read More

More premium brands to boost your value

In the past few years, increasingly health-conscious consumers have cut their alcohol use. In light of stagnating volume sales, brewer Molson Coors and distiller Diageo continue to shift their focus to premium brands. They generate higher profits to help drive your gains.
The move should also… Read More

These automakers still have long-term appeal

The global automotive industry is dealing with several long-term trends. Those include slowing sales as millennials opt for ride-sharing services instead of buying new cars, and rising tariffs that make cars more expensive.
We feel established and profitable car companies, such as the three we analyze… Read More